animal testing

News

New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to non-animal alternatives.

R&D

Organoid-based approaches may become an integral part of neurological safety testing, offering a clearer view of risk.

R&D

While support for reducing animal use has never been stronger, the path to broad adoption is steep and complex.

R&D

Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.

News

New draft guidance from the FDA says single-target antibodies will no longer need six-month toxicity testing in animals like macaques.

R&D

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.